
TUG-1375
CAS No. 2247372-59-2
TUG-1375( —— )
Catalog No. M21070 CAS No. 2247372-59-2
TUG-1375 is an ?Agonist ?of Thiazolidine Free Fatty Acid Receptor 2.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 305 | Get Quote |
![]() ![]() |
10MG | 500 | Get Quote |
![]() ![]() |
25MG | 779 | Get Quote |
![]() ![]() |
50MG | 1044 | Get Quote |
![]() ![]() |
100MG | 1404 | Get Quote |
![]() ![]() |
500MG | 2808 | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameTUG-1375
-
NoteResearch use only, not for human use.
-
Brief DescriptionTUG-1375 is an ?Agonist ?of Thiazolidine Free Fatty Acid Receptor 2.
-
DescriptionTUG-1375 is an ?Agonist ?of Thiazolidine Free Fatty Acid Receptor 2.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorFFA2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2247372-59-2
-
Formula Weight442.92
-
Molecular FormulaC22H19ClN2O4S
-
Purity>98% (HPLC)
-
SolubilityDMSO:125 mg/mL (282.22 mM)
-
SMILESCc1noc(C)c1-c1ccc(C(=O)N2C(C(=O)O)CSC2c2ccccc2Cl)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Hansen Anders H?jgaard Sergeev E Bolognini D et al. Discovery of a Potent Thiazolidine Free Fatty Acid Receptor 2 Agonist with Favorable Pharmacokinetic Properties[J]. Journal of Medicinal Chemistry 2018.
molnova catalog



related products
-
Tau protein (592-597...
Tau protein (592-597), Human (TFA) is a peptide fragment of human Tau protein.
-
Menadione sodium bis...
Menadione sodium bisulfite(MSB also known as vitamin K3)is used clinically in China to treat hemorrhagic diseases caused by vitamin K deficiency and globally as a vitamin K supplement.
-
Luxdegalutamide
Luxdegalutamide (ARV-766) is a novel, potent, and orally bioavailable proteolytic targeting chimera (PROTAC) protein degrader that degrades not only wild-type AR but also clinically relevant AR LBD mutants, including the most prevalent AR L702H, H875Y, and T878A mutations.